Dong-E-E-Jiao Co.,Ltd.

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-23 EDT			5-day change	1st Jan Change
67.89 ^CNY	-1.16%		-3.32%	+37.65%

05-24	Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2023	CI
04-25	Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Dong-E-E-Jiao Co.,Ltd. Elects Gao Dengfeng as A Director

May 27, 2020 at 03:32 pm

Dong-E-E-Jiao Co.,Ltd. announced that at AFM the company elected Gao Dengfeng as a director.

Latest news about Dong-E-E-Jiao Co.,Ltd.

Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2023	05-24	CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit	04-12	MT
Dong-E-E-Jiao's Profit Jumps 47.6% in 2023	03-22	MT
Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend	03-21	CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million.	01-24	CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024.	01-24	CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million.	01-02	CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan.	12-30	CI
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue	23-10-31	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%	23-10-10	MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Nine Months Ended 30 September 2023	23-10-10	CI
Dong-E-E-Jiao's H1 Attributable Profit Surges 72%	23-08-06	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-06	CI
Dong-E-E-Jiao Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on June 21, 2023	23-06-15	CI
Dong-E-E-Jiao Vice President, CFO Resign	23-06-14	MT
Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-24	CI
Dong-E-E-Jiao's Q1 Profit Doubles; Shares Fall 4%	23-04-26	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Dong-E-E-Jiao Estimates Higher Q1 Attributable Profit	23-04-13	MT
Dong-E-E-Jiao Sees Up to 114% Profit Jump in Q1	23-04-12	MT
Dong-E-E-Jiao Co.,Ltd. Proposes Dividend for the Year 2022	23-03-27	CI
Dong-E-E-Jiao Chairman Resigns	23-02-21	MT

Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Dong-E-E-Jiao Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

67.89 CNY

Average target price

77.86 CNY

Spread / Average Target

+14.68%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+37.65%	6.04B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-19.68%	4.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.49%	3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD	-15.69%	2.96B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-5.64%	2.43B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.89%	1.93B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-12.71%	1.59B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.27%	1.58B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.86%	1.5B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+42.40%	1.47B

Alternative Medicine